PC
PointState Capital Portfolio holdings
AUM
$4.67B
This Quarter Return
+14.93%
1 Year Return
+24.63%
3 Year Return
+80.28%
5 Year Return
+158.5%
10 Year Return
+665.76%
AUM
$4.01B
AUM Growth
+$4.01B
(+36%)
Cap. Flow
+$820M
Cap. Flow
% of AUM
20.47%
Top 10 Holdings %
Top 10 Hldgs %
45.57%
Holding
149
New
50
Increased
23
Reduced
32
Closed
33
Top Buys
| 1 |
Sunrun
RUN
|
$162M |
| 2 |
Capital One
COF
|
$146M |
| 3 |
Meta Platforms (Facebook)
META
|
$135M |
| 4 |
BILL Holdings
BILL
|
$133M |
| 5 |
Netflix
NFLX
|
$132M |
Top Sells
| 1 |
Booking.com
BKNG
|
$165M |
| 2 |
Mastercard
MA
|
$105M |
| 3 |
UnitedHealth
UNH
|
$76.8M |
| 4 |
Salesforce
CRM
|
$76.5M |
| 5 |
DuPont de Nemours
DD
|
$75.9M |
Sector Composition
| 1 | Technology | 44.02% |
| 2 | Consumer Discretionary | 15.34% |
| 3 | Communication Services | 12.22% |
| 4 | Healthcare | 9.59% |
| 5 | Financials | 7.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
BioMarin Pharmaceuticals
BMRN
$11.3B
| $5.18M | 0.1% |
59,042
-249,109
| -81% | -$21.8M |
|
77
Labcorp
LH
$22.8B
| $5.06M | 0.1% |
28,920
-94,250
| -77% | -$16.5M |
|
78
Viatris
VTRS
$12.3B
| $4.88M | 0.09% |
260,463
+49,463
| +23% | +$927K |
|
79
Bristol-Myers Squibb
BMY
$96.7B
| $4.77M | 0.09% |
+76,828
| New | +$4.77M |
|
80
Teladoc Health
TDOC
$1.37B
| $4.5M | 0.08% |
22,500
+9,000
| +67% | +$1.8M |
|
81
Intel
INTC
$105B
| $4.48M | 0.08% |
+90,000
| New | +$4.48M |
|
82
Thermo Fisher Scientific
TMO
$183B
| $4.4M | 0.08% |
+9,450
| New | +$4.4M |
|
83
Fortive
FTV
$15.9B
| $4.13M | 0.08% |
58,302
-290,202
| -83% | -$20.6M |
|
84
Zimmer Biomet
ZBH
$20.8B
| $3.87M | 0.07% |
25,853
-11,227
| -30% | -$1.68M |
|
85
FirstEnergy
FE
$25.1B
| $3M | 0.06% |
+97,874
| New | +$3M |
|
86
Intuitive Surgical
ISRG
$158B
| $2.82M | 0.05% |
10,356
-744
| -7% | -$203K |
|
87
Chemed
CHE
$6.7B
| $2.81M | 0.05% |
5,275
+3,000
| +132% | +$1.6M |
|
|
OSH
88
DELISTED
Oak Street Health, Inc.
OSH
| $2.69M | 0.05% |
44,000
-228,430
| -84% | -$14M |
|
89
Omnicell
OMCL
$1.51B
| $2.64M | 0.05% |
+22,000
| New | +$2.64M |
|
90
Charter Communications
CHTR
$35.7B
| $2.39M | 0.04% |
+3,605
| New | +$2.39M |
|
91
Immunovant
IMVT
$2.91B
| $2.16M | 0.04% |
+46,700
| New | +$2.16M |
|
92
Biogen
BIIB
$20.5B
| $2.08M | 0.04% |
+8,500
| New | +$2.08M |
|
|
HZNP
93
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $1.92M | 0.04% |
+26,250
| New | +$1.92M |
|
94
IQVIA
IQV
$31.4B
| $1.79M | 0.03% |
+10,000
| New | +$1.79M |
|
95
Tenet Healthcare
THC
$16.5B
| $1.62M | 0.03% |
40,494
+10,094
| +33% | +$403K |
|
96
Moderna
MRNA
$9.36B
| $1.57M | 0.03% |
15,000
| – | – |
|
97
Novavax
NVAX
$1.2B
| $1.34M | 0.03% |
12,000
-3,000
| -20% | -$335K |
|
98
American Financial Group
AFG
$11.5B
| $1.32M | 0.02% |
+15,024
| New | +$1.32M |
|
99
BioNTech
BNTX
$24.1B
| $1.02M | 0.02% |
+12,500
| New | +$1.02M |
|
100
Avantor
AVTR
$8.74B
| $1M | 0.02% |
+35,651
| New | +$1M |
|